Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity
- 1 August 2000
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (8) , 911-936
- https://doi.org/10.1016/s0149-2918(00)80064-8
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Hydroxyurea‐Induced Hepatitis in Human Immunodeficiency Virus‐‐Positive PatientsClinical Infectious Diseases, 1999
- Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV InfectionClinical Pharmacokinetics, 1999
- Mitochondrial sensitivity to AZTCell Biochemistry and Function, 1998
- Peripheral Neuropathy with Nucleoside AntiretroviralsDrug Safety, 1998
- Lack of mitochondrial toxicity in CEM cells treated with carbovirAntiviral Research, 1997
- Impaired mitochondrial function in microvesicular steatosis effects of drugs, ethanol, hormones and cytokinesJournal of Hepatology, 1997
- Neuropathology and pathogenesis of mitochondrial diseasesJournal of Inherited Metabolic Disease, 1996
- Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virusThe Journal of Pediatrics, 1995
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990